ADIPOQ and gout: In a previous study, Chengfei et al. reported that adiponectin affected downstream inflammatory signaling pathways in patients with gout, through the Adipo R2 signaling pathway, which ultimately reduced the production and secretion of IL‐1β in inflammatory cells.